-transparent.png){kind=logo}
Growth hormone (GH) response to the gamma-aminobutyric acid B receptor agonist, baclofen, was measured in 16 male patients with major depressive disorder and in 16 age-matched healthy male controls. No significant differences were found in the GH response to baclofen between the depressed patients and controls. On repeat testing, the GH response to baclofen showed significant retest reliability in both groups. There was no significant correlation between serum baclofen levels and the GH response to baclofen. Age significantly correlated with GH response, with older subjects having lower GH response to baclofen. These data do not suggest that a blunted GH response to baclofen. represents a specific neuroendocrine feature of major depression.
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
December 1987,
Biological psychiatry,
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
July 1994,
Biological psychiatry,
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
December 2007,
Alcohol (Fayetteville, N.Y.),
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
March 1990,
Journal of the American Academy of Child and Adolescent Psychiatry,
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
May 2011,
Psychopharmacology,
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
January 1988,
Journal of affective disorders,
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
November 1988,
Pharmacopsychiatry,
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
November 1995,
Neuroscience,
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
May 1998,
Behavioural pharmacology,
L L Davis, and
M Trivedi, and
A Choate, and
G L Kramer, and
F Petty
October 2013,
Journal of clinical psychopharmacology,
